---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287808245.md"
description: "Century Therapeutics shares are trading higher after Mizuho initiated coverage on the stock with an Outperform rating and announced an $8 price target."
datetime: "2026-05-27T18:06:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287808245.md)
  - [en](https://longbridge.com/en/news/287808245.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287808245.md)
---

# 

Century Therapeutics shares are trading higher after Mizuho initiated coverage on the stock with an Outperform rating and announced an $8 price target.

### Related Stocks

- [IPSC.US](https://longbridge.com/en/quote/IPSC.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [MFG.US](https://longbridge.com/en/quote/MFG.US.md)
- [8411.JP](https://longbridge.com/en/quote/8411.JP.md)

## Related News & Research

- [Century Therapeutics posts smaller-than-expected Q1 net loss on lower R&D spend](https://longbridge.com/en/news/286258295.md)
- [Century Therapeutics (IPSC) Swings To US$0.51 EPS Profit Challenging Persistent Loss Narratives](https://longbridge.com/en/news/278972725.md)
- [MiNK Therapeutics' Q1 net loss narrows slightly](https://longbridge.com/en/news/286558132.md)
- [Century Therapeutics (IPSC) Receives a Buy from Clear Street](https://longbridge.com/en/news/278925466.md)
- [Dyadic International Q1 net loss narrows](https://longbridge.com/en/news/286311192.md)